DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced that Matt Kane, Co-founder and Chief Executive Officer and Derek Jantz, Ph.D., Co-Founder and Chief Scientific Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference taking place virtually from January 11-14, 2021.
Details for the company presentation are as follows:
39th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 13, 2021
Time: 2:00 – 2:40 p.m. ET
A live webcast of the presentation will be accessible on the Company’s website, www.precisionbiosciences.com, in the Investors & Media section under Events and Presentations. An archived replay of the webcasts will be available for approximately 30 days following the presentations.
About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.
Investor Contact:
Alex Kelly
Interim Chief Financial Officer
Alex.Kelly@precisionbiosciences.com
Media Contact:
Maurissa Messier
Senior Director, Corporate Communications
Maurissa.Messier@precisionbiosciences.com
TruBridge Awarded for Performance in Client Experience and Customer Satisfaction: End-to-end RCM Software Outsourcing, Hospitals…
New survey finds 85% of responding independent healthcare providers say more time with patients would…
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE:…
Inventors of the sustained acoustic medicine ultrasound treatment, popular with football players and other athletes…
NASHVILLE, Tenn.--(BUSINESS WIRE)--#aesthetics--ObjectiveHealth, a Nashville-based integrated research and technology platform company, announced today that it…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading AI-driven health technology company and portfolio company of nference, announced…